Hexarelin
Examorelin
Popular for:Most potent GHRP, cardioprotective effects, GH secretion research
288
Total Studies
168
Human Studies
Animal
Evidence Level
Not Approved
FDA Status
Overview
Hexarelin is the most potent synthetic growth hormone releasing peptide, producing the largest GH pulses among the GHRP family. It is a hexapeptide that was developed as a research tool for studying maximum GH secretion capacity.
Due to its potency, Hexarelin also produces the most significant effects on cortisol and prolactin levels compared to other GHRPs. It is subject to rapid desensitization with continuous use, typically requiring cycling protocols in research settings.
Mechanism of Action
Hexarelin acts as a potent ghrelin receptor agonist at GHS-R1a, producing maximal stimulation of somatotroph cells. It also has direct cardiac effects, interacting with a non-GHS-R1a receptor (CD36) in cardiac tissue, which has been studied for cardioprotective properties independent of GH release.
Key Research Benefits
Clinical Evidence Summary
Research Pipeline
288
Total Studies
168
Human Studies
Not FDA-approved. Research compound. Primarily used in clinical research for GH secretion studies and cardiac research.
Key Studies / PubMed References
288 studies found on PubMed · showing top 25 by relevance
View all on PubMedHexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway.
In VitroGuan C, Li C, Shen X, et al. · European journal of medical research · 2023
PMID: 37710348Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation.
Animal StudyJiang B, Wang M, Li X, et al. · Microvascular research · 2022
PMID: 34856183Ghrelin receptor agonist hexarelin attenuates antinociceptive tolerance to morphine in rats.
Animal StudyBaser T, Ozdemir E, Filiz AK, et al. · Canadian journal of physiology and pharmacology · 2021
PMID: 32893668Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophythe regulation of autophagy.
In VitroAgbo E, Li MX, Wang YQ, et al. · Die Pharmazie · 2019
PMID: 31526442Modulation of PTEN by hexarelin attenuates coronary artery ligation-induced heart failure in rats.
Animal StudyAgbo E, Liu D, Li M, et al. · Turkish journal of medical sciences · 2019
PMID: 31091855Side Effects & Safety
Known Interactions
No curated interaction entry is live for Hexarelin yet.
Until the interaction table is fully populated, use the interaction checker and related peptides below to explore adjacent compounds and likely research pairings.
Frequently Asked Questions
Research Disclaimer
This page is for research and educational purposes only. The information presented is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Hexarelin is not approved by the FDA for human therapeutic use. Always consult a qualified healthcare professional before making any health-related decisions. The studies referenced are linked to their original PubMed sources for verification.